#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
ANT_2____Ia.3000230.X04555.0_750.458	ANT_2____Ia.3000230.X04555.0_750.458	1	0	528	190	ANT_2____Ia	750	213	98.15	ANT_2____Ia.l15.c17.ctg.1	679	20.3	0	.	p	.	0	F31_V32insG	INS	91	91	T	406	406	T	33	T	32	.	Plasmid or integron-encoded nucleotidylylation of 2-deoxystreptamine aminoglycosides at the hydroxyl group at position 2'' in P. aeruginosa, K. pneumoniae, Morganella morganii, E. coli, S. typhimurium, C. freundii and A. baumannii;ANT(2'')-Ia
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	556	CRP	633	633	99.53	CRP.l15.c30.ctg.1	1413	29.1	0	.	p	.	0	K29T	NONSYN	85	87	AAG	503	505	ACG	35;36;37	A;C;G	35;36;37	.	CRP is a global regulator that represses MdtEF multidrug efflux pump expression.;CRP
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	143	1738	Escherichia_coli_EF_Tu	1185	1185	99.75	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1355	87.4	1	SNP	p	L121Q	0	.	.	361	363	CTG	530	532	CTG	112;113;112	C;T;G	112;113;110	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:L121Q:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	143	1738	Escherichia_coli_EF_Tu	1185	1185	99.75	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1355	87.4	1	SNP	p	Q125K	0	.	.	373	375	CAG	542	544	CAG	115;120;121	C;A;G	114;118;121	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Q125K:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	143	1738	Escherichia_coli_EF_Tu	1185	1185	99.75	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1355	87.4	1	SNP	p	Q125E	0	.	.	373	375	CAG	542	544	CAG	115;120;121	C;A;G	114;118;121	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Q125E:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	143	1738	Escherichia_coli_EF_Tu	1185	1185	99.75	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1355	87.4	1	SNP	p	Q125R	0	.	.	373	375	CAG	542	544	CAG	115;120;121	C;A;G	114;118;121	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Q125R:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	143	1738	Escherichia_coli_EF_Tu	1185	1185	99.75	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1355	87.4	1	SNP	p	Y161D	0	.	.	481	483	TAC	650	652	TAC	115;114;112	T,C;A;C	113,1;112;112	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Y161D:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	143	1738	Escherichia_coli_EF_Tu	1185	1185	99.75	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1355	87.4	1	SNP	p	Y161N	0	.	.	481	483	TAC	650	652	TAC	115;114;112	T,C;A;C	113,1;112;112	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Y161N:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	143	1738	Escherichia_coli_EF_Tu	1185	1185	99.75	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1355	87.4	1	SNP	p	Y161C	0	.	.	481	483	TAC	650	652	TAC	115;114;112	T,C;A;C	113,1;112;112	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Y161C:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	143	1738	Escherichia_coli_EF_Tu	1185	1185	99.75	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1355	87.4	1	SNP	p	G317D	0	.	.	949	951	GGC	1118	1120	GGC	106;103;104	G;G;C	106;103;104	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:G317D:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	143	1738	Escherichia_coli_EF_Tu	1185	1185	99.75	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1355	87.4	1	SNP	p	A376S	0	.	.	1126	1128	GCA	1295	1297	GCA	86;87;90	G;C;A	85;87;90	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:A376S:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	143	1738	Escherichia_coli_EF_Tu	1185	1185	99.75	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1355	87.4	1	SNP	p	A376V	0	.	.	1126	1128	GCA	1295	1297	GCA	86;87;90	G;C;A	85;87;90	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:A376V:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	143	1738	Escherichia_coli_EF_Tu	1185	1185	99.75	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1355	87.4	1	SNP	p	E379K	0	.	.	1135	1137	GAA	1304	1306	GAA	87;85;85	G;A;A	87;85;85	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:E379K:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	143	1738	Escherichia_coli_EF_Tu	1185	1185	99.75	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1355	87.4	0	HET	.	.	.	C210T	.	210	210	C	379	379	C	89	C,T	53,36	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	143	1738	Escherichia_coli_EF_Tu	1185	1185	99.75	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1355	87.4	0	HET	.	.	.	C954T	.	954	954	C	1123	1123	C	103	C,T	54,48	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	143	1738	Escherichia_coli_EF_Tu	1185	73	100.0	Escherichia_coli_EF_Tu.l15.c17.ctg.2	184	8.6	1	SNP	p	A376S	0	.	.	1126	1128	GCA	14	16	GCA	7;7;7	G;C;A	2;2;2	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:A376S:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	143	1738	Escherichia_coli_EF_Tu	1185	73	100.0	Escherichia_coli_EF_Tu.l15.c17.ctg.2	184	8.6	1	SNP	p	A376V	0	.	.	1126	1128	GCA	14	16	GCA	7;7;7	G;C;A	2;2;2	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:A376V:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	143	1738	Escherichia_coli_EF_Tu	1185	73	100.0	Escherichia_coli_EF_Tu.l15.c17.ctg.2	184	8.6	1	SNP	p	E379K	0	.	.	1135	1137	GAA	23	25	GAA	7;8;8	G;A;A	2;3;3	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:E379K:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	804	Escherichia_coli_mutant_1	1359	1359	99.85	Escherichia_coli_mutant_1.l15.c30.ctg.1	1999	30.0	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1724	1726	AAA	21;21;21	A;A;A	21;21;21	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	1012	Escherichia_coli_mutant	1392	1392	99.43	Escherichia_coli_mutant.l15.c30.ctg.1	1877	39.7	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1324	1326	GAA	47;46;46	G,T;A;A	46,1;46;46	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	190	H_NS	414	414	99.03	H_NS.l15.c30.ctg.1	747	18.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS;H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	2702	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	781	135.4	0	.	n	.	0	A1136G	SNP	1136	1136	A	96	96	G	161	G	160	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	2702	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	781	135.4	0	.	n	.	0	T1138C	SNP	1138	1138	T	98	98	C	165	C	165	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	2702	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	781	135.4	0	.	n	.	0	T1142C	SNP	1142	1142	T	102	102	C	172	C	172	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	2702	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	781	135.4	0	.	n	.	0	C1170T	SNP	1170	1170	C	130	130	T	245	T	244	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	2702	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	781	135.4	0	.	n	.	0	T1220C	SNP	1220	1220	T	180	180	C	237	C,A	233,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	2702	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	781	135.4	0	.	n	.	0	T1245C	SNP	1245	1245	T	205	205	C	201	C	200	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	2702	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	781	135.4	0	.	n	.	0	G1253A	SNP	1253	1253	G	213	213	A	184	A	184	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	2702	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	781	135.4	0	.	n	.	0	G1256A	SNP	1256	1256	G	216	216	A	179	A	179	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	2702	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	781	135.4	0	.	n	.	0	C1258A	SNP	1258	1258	C	218	218	A	180	A	179	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	2702	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	781	135.4	0	.	n	.	0	G1266T	SNP	1266	1266	G	226	226	T	179	T	178	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	2702	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	781	135.4	0	.	n	.	0	T1267C	SNP	1267	1267	T	227	227	C	176	C	174	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	2702	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	781	135.4	0	.	n	.	0	T1275C	SNP	1275	1275	T	235	235	C	181	C	180	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	2702	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	781	135.4	0	.	n	.	0	G1276A	SNP	1276	1276	G	236	236	A	179	A	179	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	2702	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	781	135.4	0	.	n	.	0	A1281G	SNP	1281	1281	A	241	241	G	177	G	176	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	2702	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	781	135.4	0	.	n	.	0	T1283C	SNP	1283	1283	T	243	243	C	178	C	178	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	2702	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	781	135.4	0	.	n	.	0	G1288T	SNP	1288	1288	G	248	248	T	177	T	176	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	2702	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	781	135.4	0	.	n	.	0	A1296G	SNP	1296	1296	A	256	256	G	189	G	189	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	2702	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	781	135.4	0	.	n	.	0	T1299G	SNP	1299	1299	T	259	259	G	193	G	193	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	2702	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	781	135.4	0	.	n	.	0	A1300T	SNP	1300	1300	A	260	260	T	190	T	190	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	2702	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	781	135.4	0	.	n	.	0	C1356T	SNP	1356	1356	C	316	316	T	252	T	251	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	2702	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	781	135.4	0	.	n	.	0	A1358G	SNP	1358	1358	A	318	318	G	255	G	255	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	2702	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	781	135.4	0	.	n	.	0	T1368C	SNP	1368	1368	T	328	328	C	255	C,T	253,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	2702	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	781	135.4	0	.	n	.	0	G1370A	SNP	1370	1370	G	330	330	A	250	A	250	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	2702	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	781	135.4	0	.	n	.	0	C1406.	DEL	1406	1406	C	365	365	C	151	C	150	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	2702	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	781	135.4	0	.	n	.	0	.1409C	INS	1409	1409	T	369	369	C	132	C	130	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	2702	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	781	135.4	0	.	n	.	0	C1431A	SNP	1431	1431	C	391	391	A	93	A,G	91,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	2702	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	781	135.4	0	.	n	.	0	C1432A	SNP	1432	1432	C	392	392	A	100	A	100	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	2702	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	781	135.4	0	.	n	.	0	A1441G	SNP	1441	1441	A	401	401	G	120	G	118	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	2702	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	781	135.4	0	.	n	.	0	T1464C	SNP	1464	1464	T	424	424	C	132	C	132	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	2702	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	781	135.4	0	.	n	.	0	G1473T	SNP	1473	1473	G	433	433	T	170	T	168	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	2702	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	781	135.4	0	.	n	.	0	A1475G	SNP	1475	1475	A	435	435	G	175	G	173	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	2702	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	781	135.4	0	.	n	.	0	A1548T	SNP	1548	1548	A	508	508	T	158	T	158	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	2702	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	781	135.4	1	SNP	n	C1194G	0	.	.	1194	1194	C	154	154	C	258	C	258	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252:0:0:C1194G:.:Point mutations in the helix 34 region of 16S rRNA of Pasteurella multocida can confer resistance to spectinomycin	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	2702	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c17.ctg.3	280	54.9	0	.	n	.	0	T50C	SNP	50	50	T	148	148	C	91	C	91	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	2702	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c17.ctg.3	280	54.9	0	.	n	.	0	G74A	SNP	74	74	G	172	172	A	74	A	73	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	2702	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c17.ctg.3	280	54.9	0	.	n	.	0	G81.	DEL	81	81	G	178	178	A	52	A	51	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	2702	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c17.ctg.3	280	54.9	0	.	n	.	0	A83C	SNP	83	83	A	180	180	C	45	C	45	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	2702	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c17.ctg.3	280	54.9	0	.	n	.	0	T92G	SNP	92	92	T	189	189	G	18	G	17	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	2702	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c17.ctg.3	280	54.9	0	.	n	.	0	C94.	DEL	94	94	C	190	190	T	18	T,C	12,6	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	2702	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c17.ctg.3	280	54.9	0	.	n	.	0	T97C	SNP	97	97	T	193	193	C	19	C	19	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	2702	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c17.ctg.3	280	54.9	0	.	n	.	0	T128C	SNP	128	128	T	224	224	C	33	C	33	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	2702	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c17.ctg.3	280	54.9	0	.	n	.	0	T135A	SNP	135	135	T	231	231	A	36	A	36	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	2702	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c17.ctg.3	280	54.9	0	.	n	.	0	G139C	SNP	139	139	G	235	235	C	40	C	40	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	2702	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c17.ctg.3	280	54.9	0	.	n	.	0	T142G	SNP	142	142	T	238	238	G	39	G	39	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	2702	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c17.ctg.3	280	54.9	0	.	n	.	0	G159A	SNP	159	159	G	255	255	A	53	A	53	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	2702	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c17.ctg.3	280	54.9	0	.	n	.	0	G161T	SNP	161	161	G	257	257	T	52	T	52	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	2702	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c17.ctg.3	280	54.9	0	.	n	.	0	T168G	SNP	168	168	T	264	264	G	50	G	50	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	2702	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c17.ctg.3	280	54.9	0	.	n	.	0	C170T	SNP	170	170	C	266	266	T	49	T	49	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	2702	Pasteurella_multocida_16S	1551	179	90.5	Pasteurella_multocida_16S.l15.c17.ctg.3	280	54.9	0	HET	.	.	.	A82G	.	82	82	A	179	179	A	44	A,G	34,10	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	808	PmrB_1	1092	1092	99.08	PmrB_1.l15.c30.ctg.1	1613	36.9	0	.	p	.	0	H2R	NONSYN	4	6	CAT	280	282	CGT	44;45;45	C;G;T	44;45;45	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	808	PmrB_1	1092	1092	99.08	PmrB_1.l15.c30.ctg.1	1613	36.9	0	.	p	.	0	V30I	NONSYN	88	90	GTC	364	366	ATC	44;44;45	A;T;C	44;44;45	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	808	PmrB_1	1092	1092	99.08	PmrB_1.l15.c30.ctg.1	1613	36.9	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1123	1125	GGC	41;40;40	G;G;C	40;40;39	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1116	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2149	38.3	0	.	p	.	0	R8S	NONSYN	22	24	AGA	228	230	AGC	18;18;19	A;G;C	18;18;19	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1116	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2149	38.3	0	.	p	.	0	I142L	NONSYN	424	426	ATA	630	632	CTA	40;42;40	C;T;A	40;42;40	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1116	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2149	38.3	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1149	1151	CAA	58;56;56	C;A;A	58;56;56	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1116	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2149	38.3	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1248	1250	GGT	56;57;57	G;G;T	55;57;56	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1116	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2149	38.3	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1818	1820	GTT	46;48;47	G;T;T	46;48;47	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	346	PmrE	1167	1167	96.83	PmrE.l6.c30.ctg.1	1597	16.0	0	.	p	.	0	A125E	NONSYN	373	375	GCA	590	592	GAA	11;11;11	G;A;A	11;11;11	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	346	PmrE	1167	1167	96.83	PmrE.l6.c30.ctg.1	1597	16.0	0	.	p	.	0	M185T	NONSYN	553	555	ATG	770	772	ACC	16;16;16	A;C;C	16;16;16	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	346	PmrE	1167	1167	96.83	PmrE.l6.c30.ctg.1	1597	16.0	0	.	p	.	0	S225T	NONSYN	673	675	TCC	890	892	ACT	13;13;13	A;C;T	13;13;13	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	346	PmrE	1167	1167	96.83	PmrE.l6.c30.ctg.1	1597	16.0	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	1280	1282	ATC	11;11;11	A;T;C	11;11;11	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	27	622	PmrF	969	969	99.38	PmrF.l15.c4.ctg.1	1489	30.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF;PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
aadA.3002601.NC_010410.3621491_3622283.725	aadA.3002601.NC_010410.3621491_3622283.725	1	0	539	720	aad-	792	792	99.75	aad-.l15.c30.ctg.2	1469	25.1	0	.	p	.	0	A4V	NONSYN	10	12	GCG	321	323	GTG	20;20;20	G;T;G	20;20;20	.	ANT(3'')-Ia is an aminoglycoside nucleotidyltransferase gene encoded by plasmids, transposons, integrons in Enterobacteriaceae, A. baumannii, P. aeruginosa and Vibrio cholerae;aadA
acrB.3000216.DQ679966.1515_4662.624	acrB.3000216.DQ679966.1515_4662.624	1	0	16	38	acrB	3147	212	90.57	acrB.l15.c30.ctg.2	216	4.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	acrB;Protein subunit of AcrA-AcrB-TolC multidrug efflux complex. AcrB functions as a herterotrimer which forms the inner membrane component and is primarily responsible for substrate recognition and energy transduction by acting as a drug/proton antiporter.
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	1992	acrD	3114	3114	99.1	acrD.l15.c4.ctg.1	3610	40.9	0	.	p	.	0	T85I	NONSYN	253	255	ACC	583	585	ATC	47;46;46	A;T;C	47;46;45	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	1992	acrD	3114	3114	99.1	acrD.l15.c4.ctg.1	3610	40.9	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2296	2298	AAG	30;30;30	A;A;G	30;30;29	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	848	acrE	1158	1158	98.79	acrE.l15.c30.ctg.1	1621	38.9	0	.	p	.	0	A22V	NONSYN	64	66	GCC	240	242	GTC	22;22;21	G;T;C	22;22;21	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	848	acrE	1158	1158	98.79	acrE.l15.c30.ctg.1	1621	38.9	0	.	p	.	0	S269C	NONSYN	805	807	AGC	981	983	TGC	66;67;67	T;G;C	66;67;67	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	1838	acrF	3105	2598	98.5	acrF.l15.c4.ctg.1	3134	43.4	0	.	p	.	0	S46trunc	TRUNC	136	136	T	381	381	T	38	T	38	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	1838	acrF	3105	2598	98.5	acrF.l15.c4.ctg.1	3134	43.4	0	.	p	.	0	G148D	NONSYN	442	444	GGC	687	689	GAC	51;51;50	G;A;C	50;50;49	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	1838	acrF	3105	2598	98.5	acrF.l15.c4.ctg.1	3134	43.4	0	.	p	.	0	F240L	NONSYN	718	720	TTT	963	965	TTA	30;30;30	T;T;A	30;30;30	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	1838	acrF	3105	2598	98.5	acrF.l15.c4.ctg.1	3134	43.4	0	.	p	.	0	D301N	NONSYN	901	903	GAT	1146	1148	AAT	30;31;31	A;A;T	30;31;30	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	1838	acrF	3105	2598	98.5	acrF.l15.c4.ctg.1	3134	43.4	0	.	p	.	0	L563fs	FSHIFT	1687	1687	T	1933	1933	T	50	T	49	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	422	acrR_2	648	648	99.54	acrR_2.l15.c4.ctg.1	1274	24.0	1	SNP	p	R45C	0	.	.	133	135	CGC	442	444	CGC	45;45;46	C;G;C	45;45;46	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	372	acrS	663	663	98.64	acrS.l15.c4.ctg.1	1138	24.1	0	.	p	.	0	L34F	NONSYN	100	102	CTC	290	292	TTC	31;31;29	T;T;C	31;31;29	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	372	acrS	663	663	98.64	acrS.l15.c4.ctg.1	1138	24.1	0	.	p	.	0	E122G	NONSYN	364	366	GAG	554	556	GGG	26;27;27	G;G;G	26;27;27	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	390	adiY	762	762	99.61	adiY.l15.c4.ctg.1	1133	25.1	0	.	p	.	0	V136L	NONSYN	406	408	GTT	582	584	CTT	37;39;39	C;T;T	37;39;39	.	adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.;adiY
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1976	alaS	2631	2631	98.82	alaS.l15.c4.ctg.1	3411	43.2	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2186	2188	GCA	67;67;66	G;C;A	67;67;66	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1976	alaS	2631	2631	98.82	alaS.l15.c4.ctg.1	3411	43.2	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2447	2449	ACC	54;54;55	A,C;C;C	53,1;54;55	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1976	alaS	2631	2631	98.82	alaS.l15.c4.ctg.1	3411	43.2	0	.	p	.	0	P783L	NONSYN	2347	2349	CCG	2681	2683	CTG	54;54;54	C;T;G	54;54;54	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1976	alaS	2631	2631	98.82	alaS.l15.c4.ctg.1	3411	43.2	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2756	2758	GCC	43;42;42	G;C;C	42;42;42	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1048	arnA_1	1983	1983	98.29	arnA_1.l15.c17.ctg.1	2546	30.1	0	.	p	.	0	G37A	NONSYN	109	111	GGT	319	321	GCT	26;24;26	G;C;T	25;23;25	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1048	arnA_1	1983	1983	98.29	arnA_1.l15.c17.ctg.1	2546	30.1	0	.	p	.	0	D77E	NONSYN	229	231	GAT	439	441	GAG	21;22;24	G;A;G	21;22;24	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1048	arnA_1	1983	1983	98.29	arnA_1.l15.c17.ctg.1	2546	30.1	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	475	477	TGC	24;22;23	T;G;C	24;22;23	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1048	arnA_1	1983	1983	98.29	arnA_1.l15.c17.ctg.1	2546	30.1	0	.	p	.	0	I150V	NONSYN	448	450	ATT	658	660	GTT	35;33;33	G;T;T	35;33;33	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1048	arnA_1	1983	1983	98.29	arnA_1.l15.c17.ctg.1	2546	30.1	0	.	p	.	0	R200H	NONSYN	598	600	CGC	808	810	CAC	46;45;44	C;A;C	46;45;44	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1048	arnA_1	1983	1983	98.29	arnA_1.l15.c17.ctg.1	2546	30.1	0	.	p	.	0	T295M	NONSYN	883	885	ACG	1093	1095	ATG	49;50;50	A;T;G	49;50;50	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1048	arnA_1	1983	1983	98.29	arnA_1.l15.c17.ctg.1	2546	30.1	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	2089	2091	CGC	40;41;41	C;G;C	40;41;41	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	494	bacA	822	822	98.54	bacA.l15.c4.ctg.1	1469	25.1	0	.	p	.	0	S221T	NONSYN	661	663	AGC	1000	1002	ACC	28;28;28	A;C;C	28;28;28	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	494	bacA	822	822	98.54	bacA.l15.c4.ctg.1	1469	25.1	0	.	p	.	0	P225S	NONSYN	673	675	CCG	1012	1014	TCG	32;32;34	T;C;G	32;32;34	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	27	430	baeR	723	723	97.79	baeR.l15.c4.ctg.1	1462	22.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	baeR;BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	706	baeS	1404	1404	98.86	baeS.l15.c17.ctg.1	1965	26.3	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1439	1441	AAA	23;23;22	A;A;A	23;23;22	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	706	baeS	1404	1404	98.86	baeS.l15.c17.ctg.1	1965	26.3	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1451	1453	GAG	15;15;15	G;A;G	15;15;15	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	706	baeS	1404	1404	98.86	baeS.l15.c17.ctg.1	1965	26.3	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1457	1459	CAC	15;15;15	C;A;C	14;15;15	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	706	baeS	1404	1404	98.86	baeS.l15.c17.ctg.1	1965	26.3	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1511	1513	GAG	19;20;20	G;A;G	19;20;20	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
blaOXA_1.manually_added_JN003856.1_AEM36717.1_214_1044	blaOXA_1.manually_added_JN003856.1_AEM36717.1_214_1044	1	0	27	274	OXA_1+	831	831	100.0	OXA_1+.l15.c4.ctg.2	1313	14.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: JN003856.1 Salmonella enterica subsp. enterica serovar Typhimurium strain 18-425 class I integron beta-lactamase OXA-1 (blaOXA-1) and aminoglycoside adenyltransferase A (aadA1) genes, complete cds
catI.3002683.V00622.243_903.482	catI.3002683.V00622.243_903.482	1	0	27	360	cat+	660	660	99.85	cat+.l15.c4.ctg.1	1186	22.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	catI;catI is a chromosome and transposon-encoded variant of the cat gene found in Escherichia coli and Acinetobacter baumannii
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	27	840	cpxA	1374	1374	98.91	cpxA.l15.c4.ctg.1	1983	31.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxA;CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	592	cpxR	699	699	99.43	cpxR.l15.c30.ctg.1	1353	32.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.;cpxR
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	539	466	cysB	975	975	99.28	cysB.l15.c17.ctg.1	1523	22.6	0	.	p	.	0	A146T	NONSYN	436	438	GCT	706	708	ACT	34;34;35	A;C;T	34;34;35	.	Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.;aminocoumarin resistant cysB
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	736	emrA	1173	1173	98.29	emrA.l15.c4.ctg.1	1686	31.9	0	.	p	.	0	I219V	NONSYN	655	657	ATC	945	947	GTC	53;53;52	G;T;C	53;53;52	.	emrA;EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	539	1238	emrB	1539	1539	99.74	emrB.l6.c30.ctg.1	2256	40.2	0	.	p	.	0	E197K	NONSYN	589	591	GAA	918	920	AAA	56;58;57	A;A;A	56;58;57	.	emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.;emrB
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	830	emrD	1191	1191	98.4	emrD.l15.c4.ctg.1	1669	36.2	0	.	p	.	0	G209S	NONSYN	625	627	GGC	868	870	AGC	56;56;55	A;G;C	56;55;54	.	emrD;EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	19	30	emrE_1	333	290	93.79	emrE_1.l6.c30.ctg.1	524	4.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrE;EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	520	emrK	1056	1056	98.2	emrK.l15.c30.ctg.1	1571	24.1	0	.	p	.	0	K176R	NONSYN	526	528	AAG	730	732	AGG	20;20;19	A;G;G	20;20;19	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	520	emrK	1056	1056	98.2	emrK.l15.c30.ctg.1	1571	24.1	0	.	p	.	0	N306D	NONSYN	916	918	AAC	1120	1122	GAC	19;19;20	G;A;C	19;19;20	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	328	emrR	531	531	100.0	emrR.l15.c30.ctg.1	1088	21.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrR;EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	728	emrY	1539	1539	99.81	emrY.l15.c30.ctg.1	2083	25.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY;emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	286	evgA	615	615	99.19	evgA.l15.c30.ctg.1	1138	18.2	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	391	393	CTG	32;32;33	C;T;G	32;32;33	.	evgA;EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1414	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4078	25.4	0	.	p	.	0	T38I	NONSYN	112	114	ACA	409	411	ATA	33;31;30	A;T;A	33;31;30	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1414	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4078	25.4	0	.	p	.	0	L42V	NONSYN	124	126	CTA	421	423	GTA	31;33;33	G;T;A	30;32;32	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1414	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4078	25.4	0	.	p	.	0	A93T	NONSYN	277	279	GCG	574	576	ACG	28;28;28	A;C;G	28;28;28	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1414	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4078	25.4	0	.	p	.	0	A114E	NONSYN	340	342	GCA	637	639	GAA	30;29;29	G;A;A	30;29;29	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1414	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4078	25.4	0	.	p	.	0	T127A	NONSYN	379	381	ACT	676	678	GCT	24;22;21	G;C;T	24;22;21	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1414	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4078	25.4	0	.	p	.	0	N133D	NONSYN	397	399	AAT	694	696	GAT	20;19;20	G;A;T	20;19;20	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1414	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4078	25.4	0	.	p	.	0	P162S	NONSYN	484	486	CCA	781	783	TCA	19;18;18	T;C;A	19;18;18	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1414	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4078	25.4	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	910	912	CAG	22;22;21	C;A;G	22;22;21	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1414	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4078	25.4	0	.	p	.	0	I251V	NONSYN	751	753	ATT	1048	1050	GTT	23;24;24	G;T;T	23;24;24	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1414	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4078	25.4	0	.	p	.	0	N303D	NONSYN	907	909	AAT	1204	1206	GAT	14;15;15	G;A;T	14;14;15	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1414	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4078	25.4	0	.	p	.	0	S359N	NONSYN	1075	1077	AGC	1372	1374	AAT	11;11;11	A;A;T	11;11;11	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1414	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4078	25.4	0	.	p	.	0	I366L	NONSYN	1096	1098	ATA	1393	1395	TTA	12;12;12	T;T;A	12;12;12	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1414	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4078	25.4	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	1594	1596	AAA	12;12;13	A;A;A	12;12;13	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1414	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4078	25.4	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	2329	2331	CAT	20;20;20	C;A;T	20;20;20	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1414	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4078	25.4	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	2383	2385	CAT	18;18;18	C;A;T	18;18;18	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1414	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4078	25.4	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	2401	2403	AGA	17;17;16	A;G;A	17;17;16	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1414	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4078	25.4	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	2416	2418	AAT	17;17;17	A;A;T	17;17;17	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1414	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4078	25.4	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	2563	2565	TCC	22;22;22	T;C;C	22;22;22	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1414	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4078	25.4	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	2728	2730	ATT	27;28;25	A;T;T	27;28;25	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1414	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4078	25.4	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	2749	2751	GAT	25;25;25	G;A;T	25;25;25	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1414	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4078	25.4	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	2863	2865	GTT	25;24;23	G;T;T	25;24;23	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	1414	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4078	25.4	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	3148	3150	CAC	34;32;32	C;A;C	34;32;32	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	598	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1428	30.7	1	SNP	p	P64H	0	.	.	190	192	CCA	477	479	CCA	61;61;63	C;C;A	61;61;63	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	598	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1428	30.7	1	SNP	p	P64A	0	.	.	190	192	CCA	477	479	CCA	61;61;63	C;C;A	61;61;63	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	598	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1428	30.7	1	SNP	p	P64S	0	.	.	190	192	CCA	477	479	CCA	61;61;63	C;C;A	61;61;63	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	598	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1428	30.7	1	SNP	p	P64R	0	.	.	190	192	CCA	477	479	CCA	61;61;63	C;C;A	61;61;63	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	598	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1428	30.7	1	SNP	p	P64L	0	.	.	190	192	CCA	477	479	CCA	61;61;63	C;C;A	61;61;63	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	260	gadE	528	528	100.0	gadE.l15.c30.ctg.1	1088	17.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE;gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	68	gadW	729	404	95.54	gadW.l15.c4.ctg.1	427	10.3	0	.	p	.	0	K110N	NONSYN	328	330	AAA	3	5	AAT	1;1;1	A;A;T	1;1;1	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	528	68	gadW	729	404	95.54	gadW.l15.c4.ctg.1	427	10.3	0	.	p	.	0	S234A	NONSYN	700	702	TCG	375	377	GCG	7;7;8	G;C;G	7;7;8	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	340	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1302	19.5	0	.	p	.	0	F53L	NONSYN	157	159	TTC	426	428	TTA	18;18;18	T;T;A	17;17;17	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	340	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1302	19.5	0	.	p	.	0	V79I	NONSYN	235	237	GTT	504	506	ATT	21;21;21	A,T;T;T	20,1;20;20	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	340	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1302	19.5	0	.	p	.	0	R246G	NONSYN	736	738	AGA	1005	1007	GGA	22;23;22	G;G;A	22;23;22	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	340	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1302	19.5	0	.	p	.	0	S248P	NONSYN	742	744	TCG	1011	1013	CCG	24;24;23	C;C;G	24;24;23	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1808	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3306	39.9	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2331	2333	GAA	44;44;45	G;A;A	44;44;45	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1808	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3306	39.9	1	SNP	p	S83L	0	.	.	247	249	TCG	546	548	TCG	45;45;44	T;C;G	45;43;44	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1808	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3306	39.9	1	SNP	p	S83I	0	.	.	247	249	TCG	546	548	TCG	45;45;44	T;C;G	45;43;44	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1808	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3306	39.9	1	SNP	p	S83W	0	.	.	247	249	TCG	546	548	TCG	45;45;44	T;C;G	45;43;44	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1808	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3306	39.9	1	SNP	p	D87G	0	.	.	259	261	GAC	558	560	GAC	49;50;50	G;A;C	48;48;50	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1808	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3306	39.9	1	SNP	p	D87H	0	.	.	259	261	GAC	558	560	GAC	49;50;50	G;A;C	48;48;50	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1808	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3306	39.9	1	SNP	p	D87V	0	.	.	259	261	GAC	558	560	GAC	49;50;50	G;A;C	48;48;50	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1808	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3306	39.9	1	SNP	p	D87Y	0	.	.	259	261	GAC	558	560	GAC	49;50;50	G;A;C	48;48;50	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1808	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3306	39.9	1	SNP	p	D87N	0	.	.	259	261	GAC	558	560	GAC	49;50;50	G;A;C	48;48;50	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1676	gyrB_1	2415	2415	99.05	gyrB_1.l15.c30.ctg.1	3041	40.6	1	SNP	p	R136E	0	.	.	406	408	CGC	731	733	CGC	33;34;34	C;G;C	33;34;34	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1676	gyrB_1	2415	2415	99.05	gyrB_1.l15.c30.ctg.1	3041	40.6	1	SNP	p	R136I	0	.	.	406	408	CGC	731	733	CGC	33;34;34	C;G;C	33;34;34	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1676	gyrB_1	2415	2415	99.05	gyrB_1.l15.c30.ctg.1	3041	40.6	1	SNP	p	R136H	0	.	.	406	408	CGC	731	733	CGC	33;34;34	C;G;C	33;34;34	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1676	gyrB_1	2415	2415	99.05	gyrB_1.l15.c30.ctg.1	3041	40.6	1	SNP	p	R136G	0	.	.	406	408	CGC	731	733	CGC	33;34;34	C;G;C	33;34;34	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1676	gyrB_1	2415	2415	99.05	gyrB_1.l15.c30.ctg.1	3041	40.6	1	SNP	p	R136S	0	.	.	406	408	CGC	731	733	CGC	33;34;34	C;G;C	33;34;34	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1676	gyrB_1	2415	2415	99.05	gyrB_1.l15.c30.ctg.1	3041	40.6	1	SNP	p	R136L	0	.	.	406	408	CGC	731	733	CGC	33;34;34	C;G;C	33;34;34	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1676	gyrB_1	2415	2415	99.05	gyrB_1.l15.c30.ctg.1	3041	40.6	1	SNP	p	R136C	0	.	.	406	408	CGC	731	733	CGC	33;34;34	C;G;C	33;34;34	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	348	kdpE	678	678	98.23	kdpE.l6.c30.ctg.1	1218	20.9	0	.	p	.	0	A72P	NONSYN	214	216	GCG	506	508	CCG	25;23;23	C;C;G	25;23;23	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	348	kdpE	678	678	98.23	kdpE.l6.c30.ctg.1	1218	20.9	0	.	p	.	0	T123A	NONSYN	367	369	ACC	659	661	GCC	30;30;31	G;C;C	29;30;30	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	608	leuO	945	945	99.26	leuO.l15.c4.ctg.1	1321	33.8	0	.	p	.	0	P9S	NONSYN	25	27	CCA	224	226	TCA	30;31;31	T;C;A	30;31;31	.	leuO;leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	242	marA	384	384	99.74	marA.l15.c17.ctg.1	975	18.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	marA;In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	152	marR	435	435	97.7	marR.l15.c30.ctg.1	896	12.2	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	593	595	AGC	18;18;18	A;G;C	18;18;18	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	152	marR	435	435	97.7	marR.l15.c30.ctg.1	896	12.2	1	SNP	p	Y137H	1	Y137H	NONSYN	409	411	TAT	695	697	CAT	16;15;15	C;A;T	16;15;15	marR.3003378.U00096.1619119_1619554.2097:1:1:Y137H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	152	marR	435	435	97.7	marR.l15.c30.ctg.1	896	12.2	1	SNP	p	V45E	0	.	.	133	135	GTG	419	421	GTG	13;13;13	G;T;G	13;13;13	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	152	marR	435	435	97.7	marR.l15.c30.ctg.1	896	12.2	1	SNP	p	I49S	0	.	.	145	147	ATC	431	433	ATC	21;21;20	A;T;C	21;21;20	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	152	marR	435	435	97.7	marR.l15.c30.ctg.1	896	12.2	1	SNP	p	A70T	0	.	.	208	210	GCA	494	496	GCA	20;21;22	G;C;A	19;21;22	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	152	marR	435	435	97.7	marR.l15.c30.ctg.1	896	12.2	1	SNP	p	R73S	0	.	.	217	219	CGT	503	505	CGT	21;20;18	C;G;T	21;19;17	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	152	marR	435	435	97.7	marR.l15.c30.ctg.1	896	12.2	1	SNP	p	R73C	0	.	.	217	219	CGT	503	505	CGT	21;20;18	C;G;T	21;19;17	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	152	marR	435	435	97.7	marR.l15.c30.ctg.1	896	12.2	1	SNP	p	R77C	0	.	.	229	231	CGC	515	517	CGC	18;16;17	C;G;C	18;16;17	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	152	marR	435	435	97.7	marR.l15.c30.ctg.1	896	12.2	1	SNP	p	R77L	0	.	.	229	231	CGC	515	517	CGC	18;16;17	C;G;C	18;16;17	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	152	marR	435	435	97.7	marR.l15.c30.ctg.1	896	12.2	1	SNP	p	L78M	0	.	.	232	234	CTG	518	520	CTG	16;16;16	C;T;G	16;16;16	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	152	marR	435	435	97.7	marR.l15.c30.ctg.1	896	12.2	1	SNP	p	R94S	0	.	.	280	282	CGC	566	568	CGC	22;22;22	C;G;C	21;21;21	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	152	marR	435	435	97.7	marR.l15.c30.ctg.1	896	12.2	1	SNP	p	R94H	0	.	.	280	282	CGC	566	568	CGC	22;22;22	C;G;C	21;21;21	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	152	marR	435	435	97.7	marR.l15.c30.ctg.1	896	12.2	1	SNP	p	V96E	0	.	.	286	288	GTA	572	574	GTA	23;22;22	G;T;A	23;22;22	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	578	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1713	24.6	0	.	p	.	0	S7F	NONSYN	19	21	TCC	230	232	TTC	11;11;14	T;T;C	11;11;14	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	578	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1713	24.6	0	.	p	.	0	R36I	NONSYN	106	108	AGG	317	319	ATC	10;10;10	A;T;C	10;10;10	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	578	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1713	24.6	0	.	p	.	0	E42A	NONSYN	124	126	GAA	335	337	GCC	19;19;19	G;C;C	19;19;19	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	578	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1713	24.6	0	.	p	.	0	N43V	NONSYN	127	129	AAT	338	340	GTG	19;19;19	G;T;G	19;19;19	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	578	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1713	24.6	0	.	p	.	0	E52D	NONSYN	154	156	GAG	365	367	GAT	23;23;23	G;A;T	23;23;23	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	578	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1713	24.6	0	.	p	.	0	N59T	NONSYN	175	177	AAC	386	388	ACC	19;19;19	A;C;C	19;19;19	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	578	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1713	24.6	0	.	p	.	0	I68L	NONSYN	202	204	ATA	413	415	TTA	14;14;14	T;T;A	14;14;14	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	578	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1713	24.6	0	.	p	.	0	H115Q	NONSYN	343	345	CAC	554	556	CAG	29;31;32	C;A;G	29;30;32	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	578	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1713	24.6	0	.	p	.	0	D128A	NONSYN	382	384	GAC	593	595	GCC	32;32;33	G;C;C	32;32;33	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	578	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1713	24.6	0	.	p	.	0	S163A	NONSYN	487	489	TCG	698	700	GCG	48;49;48	G;C;G	48;49;48	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	578	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1713	24.6	0	.	p	.	0	L231V	NONSYN	691	693	CTT	902	904	GTT	28;29;29	G;T;T	26;25;27	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	578	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1713	24.6	0	.	p	.	0	R285fs	FSHIFT	853	853	C	1064	1064	C	40	C	39	.	Multidrug translocase MdfA;mdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	592	mdtA	1248	1248	97.36	mdtA.l15.c17.ctg.1	1803	24.4	0	.	p	.	0	V12trunc	TRUNC	34	34	G	348	348	G	26	G	26	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	592	mdtA	1248	1248	97.36	mdtA.l15.c17.ctg.1	1803	24.4	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	405	407	CAG	16;16;14	C;A;G	16;16;14	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	592	mdtA	1248	1248	97.36	mdtA.l15.c17.ctg.1	1803	24.4	0	.	p	.	0	T83I	NONSYN	247	249	ACC	555	557	ATC	25;25;26	A;T;C	24;25;26	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	592	mdtA	1248	1248	97.36	mdtA.l15.c17.ctg.1	1803	24.4	0	.	p	.	0	I99M	NONSYN	295	297	ATA	603	605	ATG	22;22;23	A;T;G	22;22;23	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	592	mdtA	1248	1248	97.36	mdtA.l15.c17.ctg.1	1803	24.4	0	.	p	.	0	A130T	NONSYN	388	390	GCC	696	698	ACC	29;29;29	A,C;C;C	28,1;29;29	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	592	mdtA	1248	1248	97.36	mdtA.l15.c17.ctg.1	1803	24.4	0	.	p	.	0	P257T	NONSYN	769	771	CCG	1077	1079	ACG	31;30;30	A;C;G	30;28;29	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1972	mdtB	3123	3123	98.98	mdtB.l15.c30.ctg.1	3725	38.9	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	2076	2078	ACC	54;54;53	A;C;C	54;54;53	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1972	mdtB	3123	3123	98.98	mdtB.l15.c30.ctg.1	3725	38.9	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2469	2471	CAA	33;31;29	C;A;A	33;31;29	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1972	mdtB	3123	3123	98.98	mdtB.l15.c30.ctg.1	3725	38.9	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2637	2639	ATT	28;28;28	A;T;T	28;27;28	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1972	mdtB	3123	3123	98.98	mdtB.l15.c30.ctg.1	3725	38.9	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2721	2723	GTT	30;29;29	G;T;T	30;29;29	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1972	mdtB	3123	3123	98.98	mdtB.l15.c30.ctg.1	3725	38.9	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2829	2831	GAG	37;35;36	G;A;G	37;35;36	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1972	mdtB	3123	3123	98.98	mdtB.l15.c30.ctg.1	3725	38.9	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	3057	3059	ATG	38;38;38	A;T;G	38;38;38	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1972	mdtB	3123	3123	98.98	mdtB.l15.c30.ctg.1	3725	38.9	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3192	3194	GAT	39;37;38	G;A;T	37;36;37	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1934	mdtC	3078	3078	98.64	mdtC.l15.c4.ctg.1	3595	39.4	0	.	p	.	0	I46M	NONSYN	136	138	ATC	371	373	ATG	19;19;18	A;T;G	18;19;17	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1934	mdtC	3078	3078	98.64	mdtC.l15.c4.ctg.1	3595	39.4	0	.	p	.	0	V208I	NONSYN	622	624	GTC	857	859	ATC	46;46;45	A;T;C	46;46;45	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1934	mdtC	3078	3078	98.64	mdtC.l15.c4.ctg.1	3595	39.4	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	3173	3175	CAC	16;16;17	C;A;C	16;16;16	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1934	mdtC	3078	3078	98.64	mdtC.l15.c4.ctg.1	3595	39.4	0	.	p	.	0	P981L	NONSYN	2941	2943	CCC	3176	3178	CTC	19;19;19	C;T;C	19;19;19	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	914	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1824	36.7	0	.	p	.	0	D3E	NONSYN	7	9	GAT	168	170	GAA	17;18;18	G;A;A	17;17;17	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	914	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1824	36.7	0	.	p	.	0	T226A	NONSYN	676	678	ACG	837	839	GCG	33;33;33	G;C;G	32;31;32	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	914	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1824	36.7	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1179	1181	ATC	55;56;58	A;T;C	55;56;58	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	914	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1824	36.7	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1482	1484	TTT	41;41;42	T;T;T,C	40;41;41,1	.	mdtD;Efflux pump mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	898	mdtE	1158	1158	99.31	mdtE.l15.c30.ctg.1	1864	35.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.;mdtE
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	2176	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3791	42.5	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1183	1185	ACC	40;40;38	A;C;C	40;40;38	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	2176	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3791	42.5	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2425	2427	GAC	49;48;47	G;A;C	49;48;47	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	680	mdtG	1227	1047	99.33	mdtG.l15.c17.ctg.1	1557	27.0	0	.	p	.	0	V200I	NONSYN	598	600	GTC	584	586	ATC	31;32;32	A;T;C	31;32;32	.	Efflux protien mdtG.;mdtG
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	680	mdtG	1227	182	99.45	mdtG.l15.c17.ctg.2	418	16.9	0	.	p	.	0	E5G	NONSYN	13	15	GAA	163	165	GGA	14;15;15	G;G;A	14;15;14	.	Efflux protien mdtG.;mdtG
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	740	mdtH	1209	1209	98.18	mdtH.l6.c30.ctg.1	1793	30.3	0	.	p	.	0	G134C	NONSYN	400	402	GGT	723	725	TGT	39;39;39	T;G;T	39;39;38	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	740	mdtH	1209	1209	98.18	mdtH.l6.c30.ctg.1	1793	30.3	0	.	p	.	0	S324L	NONSYN	970	972	TCG	1293	1295	TTG	42;42;39	T;T;G	41;42;39	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	740	mdtH	1209	1209	98.18	mdtH.l6.c30.ctg.1	1793	30.3	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1503	1505	ACG	6;6;6	A;C;G	6;6;6	.	mdtH;Multidrug resistance protein MdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	872	mdtL	1176	1176	98.38	mdtL.l15.c4.ctg.1	1868	34.5	0	.	p	.	0	A185S	NONSYN	553	555	GCC	927	929	TCC	21;21;22	T;C;C	21;21;22	.	Multidrug resistance protein MdtL;mdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	642	mdtN	1032	1032	98.06	mdtN.l15.c30.ctg.1	1789	26.6	0	.	p	.	0	V119I	NONSYN	355	357	GTT	721	723	ATT	48;48;49	A;T;T	48;48;49	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.;mdtN
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1216	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2728	32.6	0	.	p	.	0	V11M	NONSYN	31	33	GTG	364	366	ATG	20;20;20	A;T;G	20;20;20	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1216	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2728	32.6	0	.	p	.	0	T33I	NONSYN	97	99	ACC	430	432	ATC	17;18;18	A;T;C	17;18;18	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1216	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2728	32.6	0	.	p	.	0	C116R	NONSYN	346	348	TGC	679	681	CGC	36;36;36	C;G;C	36;35;36	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1216	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2728	32.6	0	.	p	.	0	N238S	NONSYN	712	714	AAC	1045	1047	AGC	35;35;36	A;G;C	35;35;35	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1216	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2728	32.6	0	.	p	.	0	M305V	NONSYN	913	915	ATG	1246	1248	GTG	27;26;26	G;T;G	26;25;26	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1216	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2728	32.6	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1309	1311	AAC	38;37;37	A;A,C;C	28;26,1;32	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1216	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2728	32.6	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	1354	1356	GTC	42;42;40	G;T;C	42;42;40	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1216	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2728	32.6	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1384	1386	ATA	38;38;39	A;T;A	38;38;39	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1216	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2728	32.6	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1492	1494	TCT	47;47;48	T;C;T	46;47;48	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1216	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2728	32.6	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1879	1881	GCG	35;33;33	G;C;G	34;33;33	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1216	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2728	32.6	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	2092	2094	ATC	47;46;46	A;T;C	47;46;46	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	780	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	1897	29.9	0	.	p	.	0	S129A	NONSYN	385	387	TCA	666	668	GCG	47;46;45	G;C;G	47;45;45	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	780	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	1897	29.9	0	.	p	.	0	A187T	NONSYN	559	561	GCC	840	842	ACC	44;44;43	A;C;C	44;44;43	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	780	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	1897	29.9	0	.	p	.	0	H211R	NONSYN	631	633	CAC	912	914	CGC	48;46;47	C;G;C	48;46;46	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	780	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	1897	29.9	0	.	p	.	0	V250A	NONSYN	748	750	GTT	1029	1031	GCT	32;33;32	G;C;T	32;33;31	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	780	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	1897	29.9	0	.	p	.	0	A271V	NONSYN	811	813	GCC	1092	1094	GTC	46;46;46	G;T;C	46;44;46	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	780	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	1897	29.9	0	.	p	.	0	R278K	NONSYN	832	834	AGA	1113	1115	AAA	33;32;32	A;A;A	33;32;31	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	780	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	1897	29.9	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	1131	1133	CGA	26;26;26	C;G;A	26;26;26	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	780	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	1897	29.9	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1296	1298	GCC	17;17;19	G;C;C	17;17;19	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	780	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	1897	29.9	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1308	1310	GAT	25;26;27	G;A;T	25;25;27	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	780	mdtP	1467	1467	97.89	mdtP.l15.c30.ctg.1	1897	29.9	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1725	1727	GCT	19;20;20	G;C;T	19;20;20	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	2064	mfd	3447	3447	99.16	mfd.l15.c30.ctg.1	4101	36.7	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1630	1632	AAG	28;27;27	A;A;G	28;27;27	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	2064	mfd	3447	3447	99.16	mfd.l15.c30.ctg.1	4101	36.7	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2707	2709	CTG	39;37;37	C;T;G	39;36;37	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	27	152	mgrB	144	144	100.0	mgrB.l15.c30.ctg.1	611	18.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB;mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1250	msbA	1749	1749	98.68	msbA.l15.c4.ctg.1	2412	38.4	0	.	p	.	0	S278N	NONSYN	832	834	AGC	1149	1151	AAC	40;41;42	A;A;C	39;40;41	.	msbA;MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1250	msbA	1749	1749	98.68	msbA.l15.c4.ctg.1	2412	38.4	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1695	1697	ATA	59;59;57	A;T;A	59;59;57	.	msbA;MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	998	murA_12	1260	1260	98.49	murA_12.l15.c30.ctg.1	2006	36.7	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1386	1388	GAT	54;54;53	G;A;T	54;54;53	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	998	murA_12	1260	1260	98.49	murA_12.l15.c30.ctg.1	2006	36.7	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1389	1391	CTG	53;53;49	C;T;G	53;53;49	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	398	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1267	23.3	0	.	p	.	0	R27C	NONSYN	79	81	CGT	325	327	TGT	25;24;24	T;G;T	25;24;24	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	398	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1267	23.3	0	.	p	.	0	I117T	NONSYN	349	351	ATC	595	597	ACC	41;39;38	A;C;C	40;38;38	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	398	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1267	23.3	0	.	p	.	0	G187D	NONSYN	559	561	GGC	805	807	GAC	30;30;30	G;A;C	30;30;30	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	398	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1267	23.3	1	SNP	p	R15C	0	.	.	43	45	CGC	289	291	CGC	37;37;36	C;G;C	36;36;35	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	398	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1267	23.3	1	SNP	p	S33R	0	.	.	97	99	AGC	343	345	AGC	27;27;27	A;G;C	27;27;27	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	398	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1267	23.3	1	SNP	p	G131D	0	.	.	391	393	GGC	637	639	GGC	36;36;35	G;G;C	36;36;35	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	398	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1267	23.3	1	SNP	p	R203L	0	.	.	607	609	CGT	853	855	CGT	37;35;35	C;G;T	37;35;34	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203L:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	398	nfsA	723	723	99.03	nfsA.l15.c30.ctg.1	1267	23.3	1	SNP	p	R203C	0	.	.	607	609	CGT	853	855	CGT	37;35;35	C;G;T	37;35;34	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	788	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1664	34.7	0	.	p	.	0	D312E	NONSYN	934	936	GAT	1110	1112	GAG	39;41;42	G;A;G,T	39;41;40,1	.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	788	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1664	34.7	1	SNP	p	G141E	0	.	.	421	423	GGT	597	599	GGT	51;52;53	G;G;T	51;52;53	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	788	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1664	34.7	1	SNP	p	G141D	0	.	.	421	423	GGT	597	599	GGT	51;52;53	G;G;T	51;52;53	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	788	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1664	34.7	1	SNP	p	R154A	0	.	.	460	462	CGT	636	638	CGT	53;51;50	C;G;T	53;51;50	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	788	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1664	34.7	1	SNP	p	R154D	0	.	.	460	462	CGT	636	638	CGT	53;51;50	C;G;T	53;51;50	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1718	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2873	43.7	0	.	p	.	0	A533V	NONSYN	1597	1599	GCG	1898	1900	GTG	61;62;62	G;T;G	61;61;62	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1718	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2873	43.7	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1925	1927	TCG	63;63;64	T;C;G,A	61;62;62,1	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1718	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2873	43.7	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2540	2542	AAC	37;34;34	A;A,G;C	35;33,1;33	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1718	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2873	43.7	1	SNP	p	A85T	0	.	.	253	255	GCG	554	556	GCG	56;59;60	G;C;G	56;59;60	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1718	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2873	43.7	1	SNP	p	D111H	0	.	.	331	333	GAT	632	634	GAT	43;44;44	G;A;T	42;43;42	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1718	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2873	43.7	1	SNP	p	S129P	0	.	.	385	387	TCC	686	688	TCC	51;52;52	T;C;C	51;51;51	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	1218	parE_1	1893	1893	97.52	parE_1.l6.c30.ctg.1	2551	35.4	0	.	p	.	0	D473N	NONSYN	1417	1419	GAC	1731	1733	AAC	49;48;48	A;A;C	48;47;46	.	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	1218	parE_1	1893	1893	97.52	parE_1.l6.c30.ctg.1	2551	35.4	1	SNP	p	D476N	0	.	.	1426	1428	GAT	1740	1742	GAT	52;52;54	G;A;T	51;51;54	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	1014	patA	1380	1380	99.78	patA.l15.c17.ctg.1	2078	36.0	0	.	p	.	0	P202Q	NONSYN	604	606	CCG	946	948	CAG	43;42;42	C;A;G	43;42;42	.	patA;PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	1014	patA	1380	1380	99.78	patA.l15.c17.ctg.1	2078	36.0	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1420	1422	GAT	45;42;43	G;A;T	44;41;42	.	patA;PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2858	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4747	44.1	1	SNP	p	V146F	0	.	.	436	438	GTT	793	795	GTT	30;29;31	G;T;T	30;29;31	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2858	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4747	44.1	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1894	1896	CAG	54;54;53	C;A;G	54;54;53	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2858	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4747	44.1	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1894	1896	CAG	54;54;53	C;A;G	54;54;53	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2858	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4747	44.1	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1933	1935	CAC	49;50;51	C;A;C	49;48;51	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2858	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4747	44.1	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1942	1944	CGT	45;46;45	C;G;T	45;46;45	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2858	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4747	44.1	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1942	1944	CGT	45;46;45	C;G;T	45;46;45	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2858	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4747	44.1	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1948	1950	TCC	43;44;44	T;C;C	43;44;44	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2858	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4747	44.1	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1954	1956	CTC	46;46;47	C;T;C	46;45;47	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2858	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4747	44.1	1	SNP	p	T563P	0	.	.	1687	1689	ACC	2044	2046	ACC	55;56;57	A;C;C,T	55;56;56,1	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2858	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4747	44.1	1	SNP	p	P564L	0	.	.	1690	1692	CCT	2047	2049	CCT	58;59;58	C;C;T	58;59;57	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2858	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4747	44.1	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2416	2418	CGT	88;87;88	C;G;T	87;86;87	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	8586	rrsB+	1542	503	100.0	rrsB+.l15.c30.ctg.1	774	272.2	1	SNP	n	A1519T	0	.	.	1519	1519	A	480	480	A	331	A	327	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	8586	rrsB+	1542	503	100.0	rrsB+.l15.c30.ctg.1	774	272.2	1	SNP	n	A1519G	0	.	.	1519	1519	A	480	480	A	331	A	327	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	8586	rrsB+	1542	503	100.0	rrsB+.l15.c30.ctg.1	774	272.2	1	SNP	n	A1519C	0	.	.	1519	1519	A	480	480	A	331	A	327	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	8586	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1027	346.2	0	.	n	.	0	A226G	SNP	226	226	A	252	252	G	404	G	400	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	8586	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1027	346.2	1	SNP	n	A794T	0	.	.	794	794	A	820	820	A	364	A	355	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	8586	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1027	346.2	1	SNP	n	A794G	0	.	.	794	794	A	820	820	A	364	A	355	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	8586	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1027	346.2	1	SNP	n	G926A	0	.	.	926	926	G	952	952	G	282	G	282	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	8586	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1027	346.2	1	SNP	n	G926C	0	.	.	926	926	G	952	952	G	282	G	282	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	8586	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1027	346.2	1	SNP	n	G926T	0	.	.	926	926	G	952	952	G	282	G	282	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	8586	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1027	346.2	0	HET	.	.	.	A79G	.	79	79	A	105	105	A	379	A,G	278,98	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	8586	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1027	346.2	0	HET	.	.	.	C719T	.	719	719	C	745	745	C	372	C,T	219,153	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	8586	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1027	346.2	0	HET	.	.	.	T273A,C	.	273	273	T	299	299	T	351	T,A,C	257,89,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	8586	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1027	346.2	0	HET	.	.	.	C183T,G	.	183	183	C	209	209	C	333	C,T,G	210,121,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	8586	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1027	346.2	0	HET	.	.	.	A250T	.	250	250	A	276	276	A	366	A,T	262,95	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	8586	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1027	346.2	0	HET	.	.	.	T90C	.	90	90	T	116	116	T	365	T,C	269,96	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	8586	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1027	346.2	0	HET	.	.	.	G474A	.	474	474	G	500	500	G	370	G,A	283,86	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	8586	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1027	346.2	0	HET	.	.	.	A253T,G	.	253	253	A	279	279	A	359	A,T,G	258,95,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	8586	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1027	346.2	0	HET	.	.	.	C194T	.	194	194	C	220	220	C	358	C,T	277,79	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	8586	rrsB+	1542	185	96.24	rrsB+.l15.c30.ctg.3	185	75.0	0	.	n	.	0	G1002A	SNP	1002	1002	G	75	75	A	87	A,G	86,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	8586	rrsB+	1542	185	96.24	rrsB+.l15.c30.ctg.3	185	75.0	0	.	n	.	0	G1006C	SNP	1006	1006	G	79	79	C	87	C,G	85,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	8586	rrsB+	1542	185	96.24	rrsB+.l15.c30.ctg.3	185	75.0	0	.	n	.	0	T1010C	SNP	1010	1010	T	83	83	C	87	C,T	85,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	8586	rrsB+	1542	185	96.24	rrsB+.l15.c30.ctg.3	185	75.0	0	.	n	.	0	A1019.	DEL	1019	1019	A	91	91	G	87	G	86	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	8586	rrsB+	1542	185	96.24	rrsB+.l15.c30.ctg.3	185	75.0	0	.	n	.	0	.1023G	INS	1023	1023	T	96	96	G	88	G	86	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	8586	rrsB+	1542	185	96.24	rrsB+.l15.c30.ctg.3	185	75.0	0	.	n	.	0	C1038T	SNP	1038	1038	C	111	111	T	95	T,C	92,2	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	645	8586	rrsB+	1542	179	100.0	rrsB+.l15.c30.ctg.4	179	82.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	556	soxR	465	465	100.0	soxR.l6.c4.ctg.1	1030	39.9	1	SNP	p	R20H	0	.	.	58	60	CGC	338	340	CGC	65;64;67	C;G;C	65;63;67	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	556	soxR	465	465	100.0	soxR.l6.c4.ctg.1	1030	39.9	1	SNP	p	G121D	0	.	.	361	363	GGT	641	643	GGT	63;63;64	G;G;T	63;63;64	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	302	soxS_1	324	324	99.69	soxS_1.l15.c4.ctg.1	956	23.7	1	SNP	p	A12S	0	.	.	34	36	GCA	336	338	GCA	56;56;55	G;C;A	56;56;55	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
tetA.3000165.NC_020418.458865_460071.275	tetA.3000165.NC_020418.458865_460071.275	1	0	539	680	tet-	1206	1206	99.92	tet-.l15.c30.ctg.1	1652	30.3	0	.	p	.	0	T171A	NONSYN	511	513	ACT	793	795	GCT	26;26;26	G;C;T	26;26;26	.	tetA;TetA is a tetracycline efflux pump found in many species of Gram-negative bacteria.
tetC.manually_added_J01830_AAB59095.1_2926_3519	tetC.manually_added_J01830_AAB59095.1_2926_3519	1	0	539	178	tetC	594	594	99.66	tetC.l15.c4.ctg.1	904	13.7	0	.	p	.	0	S152D	NONSYN	454	456	AGT	670	672	GAT	19;19;17	G;A;T	19;19;17	.	Original ref seq: J01830.1 Transposon Tn10 tetracycline resistance and repressor genes tetA and tetR, complete cds
tetD.3000168.BX664015.204137_204554.417	tetD.3000168.BX664015.204137_204554.417	1	0	27	196	tetD	417	417	100.0	tetD.l15.c4.ctg.1	969	14.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TetD is a tetracycline efflux pump found exclusively in Gram-negative bacteria.;tetD
tetR.3003479.AL513383.179218_179845.2090	tetR.3003479.AL513383.179218_179845.2090	1	1	27	366	tetR_2	627	627	100.0	tetR_2.l15.c4.ctg.1	1114	23.7	1	SNP	p	H64Y	0	.	.	190	192	CAC	432	434	CAC	24;26;27	C;A;C	24;26;27	tetR.3003479.AL513383.179218_179845.2090:1:1:H64Y:.:TetR is the repressor of the tetracycline resistance element; its N-terminal region forms a helix-turn-helix structure and binds DNA. Binding of tetracycline to TetR reduces the repressor affinity for the tetracycline resistance gene (tetA) promoter operator sites. Mutations arise within tetR results in lower affinity for tetracyclin	tetR
tetR.3003479.AL513383.179218_179845.2090	tetR.3003479.AL513383.179218_179845.2090	1	1	27	366	tetR_2	627	627	100.0	tetR_2.l15.c4.ctg.1	1114	23.7	1	SNP	p	N82H	0	.	.	244	246	AAT	486	488	AAT	25;25;25	A;A;T	25;25;25	tetR.3003479.AL513383.179218_179845.2090:1:1:N82H:.:TetR is the repressor of the tetracycline resistance element; its N-terminal region forms a helix-turn-helix structure and binds DNA. Binding of tetracycline to TetR reduces the repressor affinity for the tetracycline resistance gene (tetA) promoter operator sites. Mutations arise within tetR results in lower affinity for tetracyclin	tetR
tetR.manually_added_J01830_AAB59093.1_903_1526	tetR.manually_added_J01830_AAB59093.1_903_1526	1	0	27	366	tetR_1	624	624	100.0	tetR_1.l15.c4.ctg.1	1114	23.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: J01830.1 Transposon Tn10 tetracycline resistance and repressor genes tetA and tetR, complete cds
tetR.manually_added_NC_009345_WP_000164043.1_474_1124	tetR.manually_added_NC_009345_WP_000164043.1_474_1124	1	0	16	14	tetR	651	180	99.44	tetR.l6.c4.ctg.1	180	2.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	1030	tolC	1488	1488	98.72	tolC.l15.c30.ctg.1	2100	35.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	tolC;TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.
